U.S Physical Therapy Net Profit Margin 2010-2023 | USPH

U.S Physical Therapy net profit margin from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
U.S Physical Therapy Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2023-12-31 $0.61B $0.03B 4.63%
2023-09-30 $0.59B $0.03B 5.08%
2023-06-30 $0.58B $0.03B 5.34%
2023-03-31 $0.57B $0.03B 5.43%
2022-12-31 $0.55B $0.03B 5.96%
2022-09-30 $0.54B $0.04B 7.37%
2022-06-30 $0.53B $0.04B 7.56%
2022-03-31 $0.52B $0.04B 7.96%
2021-12-31 $0.50B $0.04B 8.08%
2021-09-30 $0.48B $0.04B 8.92%
2021-06-30 $0.47B $0.04B 9.46%
2021-03-31 $0.42B $0.04B 9.95%
2020-12-31 $0.42B $0.04B 8.27%
2020-09-30 $0.43B $0.03B 7.01%
2020-06-30 $0.44B $0.03B 6.42%
2020-03-31 $0.48B $0.03B 6.90%
2019-12-31 $0.48B $0.04B 8.32%
2019-09-30 $0.48B $0.04B 8.82%
2019-06-30 $0.47B $0.04B 8.69%
2019-03-31 $0.46B $0.04B 7.59%
2018-12-31 $0.45B $0.03B 7.51%
2018-09-30 $0.45B $0.03B 6.97%
2018-06-30 $0.44B $0.03B 6.44%
2018-03-31 $0.42B $0.02B 5.66%
2017-12-31 $0.41B $0.02B 5.31%
2017-09-30 $0.40B $0.02B 5.05%
2017-06-30 $0.38B $0.02B 5.25%
2017-03-31 $0.37B $0.02B 5.72%
2016-12-31 $0.36B $0.02B 5.62%
2016-09-30 $0.35B $0.02B 5.68%
2016-06-30 $0.35B $0.02B 6.03%
2016-03-31 $0.34B $0.02B 6.16%
2015-12-31 $0.33B $0.02B 6.34%
2015-09-30 $0.32B $0.02B 5.88%
2015-06-30 $0.32B $0.02B 5.68%
2015-03-31 $0.31B $0.02B 5.77%
2014-12-31 $0.31B $0.02B 5.90%
2014-09-30 $0.30B $0.02B 6.44%
2014-06-30 $0.28B $0.01B 4.95%
2014-03-31 $0.27B $0.01B 4.78%
2013-12-31 $0.27B $0.01B 4.91%
2013-09-30 $0.26B $0.01B 5.06%
2013-06-30 $0.25B $0.02B 7.11%
2013-03-31 $0.25B $0.02B 7.20%
2012-12-31 $0.25B $0.02B 7.20%
2012-09-30 $0.24B $0.02B 9.02%
2012-06-30 $0.24B $0.02B 8.68%
2012-03-31 $0.24B $0.02B 8.82%
2011-12-31 $0.23B $0.02B 9.05%
2011-09-30 $0.23B $0.02B 7.39%
2011-06-30 $0.22B $0.02B 7.62%
2011-03-31 $0.22B $0.02B 7.37%
2010-12-31 $0.21B $0.02B 7.14%
2010-09-30 $0.21B $0.01B 6.28%
2010-06-30 $0.21B $0.01B 5.85%
2010-03-31 $0.20B $0.01B 5.91%
2009-12-31 $0.20B $0.01B 5.97%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.601B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.956B 10.26
Quest Diagnostics (DGX) United States $15.068B 15.57
DaVita (DVA) United States $12.004B 14.91
Chemed (CHE) United States $8.645B 26.80
Encompass Health (EHC) United States $8.509B 21.78
Elanco Animal Health (ELAN) United States $6.552B 14.90
Option Care Health (OPCH) United States $5.218B 19.75
RadNet (RDNT) United States $3.843B 104.00
Amedisys (AMED) United States $3.017B 21.38
LifeStance Health (LFST) United States $2.641B 0.00
Astrana Health (ASTH) United States $2.147B 26.80
Addus HomeCare (ADUS) United States $1.602B 22.92
Pennant (PNTG) United States $0.647B 34.24
Aveanna Healthcare Holdings (AVAH) United States $0.456B 0.00
Atai Life Sciences (ATAI) Germany $0.355B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.012B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00